E2F4/E2F5 (E2F4/5) (Internal Region) anticorps
-
- Antigène Voir toutes E2F4/E2F5 (E2F4/5) Anticorps
- E2F4/E2F5 (E2F4/5)
-
Épitope
- Internal Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Inconjugué
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Réactivité croisée
- Humain, Singe, Souris, Rat
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from the Internal region of Human E2F-4/5.
- Isotype
- IgG
-
-
- Indications d'application
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:40000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- E2F4/E2F5 (E2F4/5)
- Autre désignation
- E2F4/E2F5 (E2F4/5 Produits)
- Synonymes
- anticorps AU024671, anticorps E2F-5, anticorps E2f-5, anticorps E2F transcription factor 5, anticorps E2f5
- Sujet
- E2F4, Transcription factor E2F4, E2F-4, E2F5, Transcription factor E2F5, E2F-5
- UniProt
- Q16254, Q15329
- Pathways
- Mitotic G1-G1/S Phases
-